High-risk prostate cancer: is androgen deprivation monotherapy still appropriate?

被引：0
|
作者：
Shahinian, Vahakn B. [1 ]
机构：
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
来源：
ASIAN JOURNAL OF ANDROLOGY | 2012年 / 14卷 / 03期
关键词：
EXTERNAL-BEAM RADIOTHERAPY; RADIATION-THERAPY; TRIAL; SUPPRESSION;
D O I：
10.1038/aja.2011.182
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [31] High-risk prostate cancer: combination of high-dose, high-precision radiotherapy and androgen deprivation therapy
    Bolla, Michel
    Verry, Camille
    Long, Jean-Alexandre
    [J]. CURRENT OPINION IN UROLOGY, 2013, 23 (04) : 349 - 354
  • [32] Optimal Duration of Androgen Deprivation in Combination with Radiation Therapy for Japanese Men with High-Risk Prostate Cancer
    Takaha, Natsuki
    Okihara, Koji
    Kamoi, Kazumi
    Kimura, Yasunori
    Yamada, Takeshi
    Kawauchi, Akihiro
    Kobayashi, Kana
    Yamazaki, Hideya
    Nishimura, Tsunehiko
    Miki, Tsuneharu
    [J]. UROLOGIA INTERNATIONALIS, 2011, 87 (01) : 28 - 34
  • [33] Effects of androgen deprivation therapy on elderly men with high-risk prostate cancer: PROSARC observational study
    Legido-Gomez, O.
    Rico-Marco, S.
    Lorenzo-Sanchez, M. V.
    Navarro-Jimenez, S.
    Tarraga-Honrubia, M. A.
    Martinez-Ruiz, J.
    Gimenez-Bachs, J. M.
    Donate-Moreno, M. J.
    Mera-Sanchez-Migallon, I. Diaz de
    Segura-Martin, M.
    Alcantud-Corcoles, R.
    Abizanda-Soler, P.
    Salinas-Sanchez, A. S.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2024, 48 (04): : 304 - 310
  • [34] Preoperative Androgen Deprivation Therapy for Localized Prostate Cancer: Delayed Biochemical Recurrence in High-Risk Disease
    Pal, Sumanta K.
    Ruel, Nora
    Vogelzang, Nicholas
    Chang, Mark
    Wilson, Timothy G.
    Jones, Jeremy O.
    Yuh, Bertram
    [J]. CLINICAL GENITOURINARY CANCER, 2014, 12 (03) : 149 - 154
  • [35] The role of androgen deprivation therapy prior to radical prostatectomy in high-risk prostate cancer: a systematic review
    Arroyo-Rojas, Yenny
    Rodriguez-Sanchez, Lara
    Colandrea, Gianmarco
    Arca, Hugo Otaola
    Lanz, Camille
    Barret, Eric
    Sanchez-Salas, Rafael
    Macek, Petr
    Cathelineau, Xavier
    [J]. MINERVA UROLOGY AND NEPHROLOGY, 2024, 76 (02): : 141 - 147
  • [36] THE OUTCOMES OF RADICAL PROSTATECTOMY MONOTHERAPY IN HIGH-RISK PROSTATE CANCER
    Joniau, S.
    Gontero, P.
    Spahn, M.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 218 - 218
  • [37] Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy:quality of life in high-risk prostate cancer patients
    Seok-HoKang
    Jin-WookKim
    Jae-HyunBae
    Hong-SeokPark
    Du-GeonMoon
    Duck-KiYoon
    JunCheon
    Je-JongKim
    [J]. Asian Journal of Andrology, 2006, (05) : 629 - 636
  • [38] Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: quality of life in high-risk prostate cancer patients
    Kang, Seok-Ho
    Kim, Jin-Wook
    Bae, Jae-Hyun
    Park, Hong-Seok
    Moon, Du-Geon
    Yoon, Duck-Ki
    Cheon, Jun
    Kim, Je-Jong
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2006, 8 (05) : 629 - 636
  • [39] Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer
    Shahinian, VB
    Kuo, YF
    Freeman, JL
    Goodwin, JS
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (04) : 465 - 471
  • [40] High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer
    Patel, Shyamal
    Demanes, D. Jeffrey
    Ragab, Omar
    Zhang, Mingle
    Veruttipong, Darlene
    Nguyen, Kristine
    Park, Sang-June
    Marks, Leonard
    Pantuck, Allan
    Steinberg, Michael
    Kamrava, Mitchell
    [J]. BRACHYTHERAPY, 2017, 16 (02) : 299 - 305
12345